BBB Cancer Research Results
BBB, Blood-Brain Barrier Permeability: Click to Expand ⟱
| Source: |
| Type: |
Blood-Brain Barrier(BBB) is a term often used regarding if a product has the ability to cross the BBB.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*BBB↝,
*BBB↝, *BBB↓, *fatigue↓, *other↝,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*RenoP↓, Casp3↑, Casp8↑, MDA↑, GSH↓, SOD↓, Catalase↓, VEGF↓, Bcl-2↓, TumCG↓, p‑Akt↓, PI3K↓, TumCCA↑, TumCP↓, BMP7/OP1↓, *ZO-1↑, *BBB↝, *p‑Akt↑, *GSK‐3β↑, *SOD↑, *Catalase↑, *GSH↑, *SIRT1↑, *NF-kB↓, *IL1β↓, *IL6↓, *IL8↓, *TNF-α↓, *ROS↓, *MDA↓, *BAX↓, *Casp3↓, *Bcl-2↑, *BDNF↑, *TrkB↑, *NGF↑, *Apoptosis↓, *cardioP↑, *AST↓, *hepatoP↑, *AST↓, *ALAT↓, *MDA↓, *BACH1↓, *neuroP↑, *Stroke↓, *ICAM-1↓, *VCAM-1↓, *TLR4↓, *COX2/PTGS2↓, *RenoP↑, *NLRP3↓, *Casp1↓, *ASC↓, *BioAv↓, *BioAv↑, *toxicity↓,
| - |
vitro+vivo, |
Nor, |
RAW264.7 |
|
|
|
*Inflam↓, *GSK‐3β↓, *TNF-α↓, *IL6↓, *IL1β↓, *p‑GSK‐3β↑, *eff↑, *COX2/PTGS2↓, *ERK↓, *NF-kB↓, *NRF2↑, *HO-1↑, *OCLN↑, *ZO-1↑, *BBB↝,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
BMP7/OP1↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↓, 1, GSH↓, 1, MDA↑, 1, SOD↓, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Bcl-2↓, 1, Casp3↑, 1, Casp8↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PI3K↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
TumCP↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGF↓, 1,
Total Targets: 14
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
Stroke↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↑, 1, GSH↑, 1, HO-1↑, 1, MDA↓, 2, NRF2↑, 1, ROS↓, 1, SOD↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1, SIRT1↑, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↑, 1, Apoptosis↓, 1, BAX↓, 1, Bcl-2↑, 1, Casp1↓, 1, Casp3↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ERK↓, 1, GSK‐3β↓, 1, GSK‐3β↑, 1, p‑GSK‐3β↑, 1,
Migration(tgid=13) ⓘ
BACH1↓, 1, VCAM-1↓, 1, ZO-1↑, 2,
Barriers & Transport(tgid=15) ⓘ
BBB↓, 1, BBB↝, 4, OCLN↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
ASC↓, 1, COX2/PTGS2↓, 2, ICAM-1↓, 1, IL1β↓, 2, IL6↓, 2, IL8↓, 1, Inflam↓, 1, NF-kB↓, 2, TLR4↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission(tgid=18) ⓘ
BDNF↑, 1, NGF↑, 1, TrkB↑, 1,
Protein Aggregation(tgid=19) ⓘ
NLRP3↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 2, IL6↓, 2,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, fatigue↓, 1, hepatoP↑, 1, neuroP↑, 1, RenoP↓, 1, RenoP↑, 1, toxicity↓, 1,
Total Targets: 54
Scientific Paper Hit Count for: BBB, Blood-Brain Barrier Permeability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1123 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page